A detailed history of Pfs Investments Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Pfs Investments Inc. holds 43,011 shares of VRTX stock, worth $21.6 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
43,011
Previous 42,861 0.35%
Holding current value
$21.6 Million
Previous $13.8 Million 9.78%
% of portfolio
0.25%
Previous 0.24%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$314.42 - $351.91 $47,163 - $52,786
150 Added 0.35%
43,011 $15.1 Million
Q1 2023

May 15, 2023

BUY
$283.23 - $323.1 $101,113 - $115,346
357 Added 0.84%
42,861 $13.8 Million
Q4 2022

Feb 13, 2023

SELL
$285.76 - $321.48 $445,785 - $501,508
-1,560 Reduced 3.54%
42,504 $12.3 Million
Q3 2022

Nov 14, 2022

SELL
$273.83 - $305.53 $1.65 Million - $1.84 Million
-6,014 Reduced 12.01%
44,064 $12.8 Million
Q2 2022

Aug 12, 2022

SELL
$234.96 - $292.55 $1.6 Million - $1.99 Million
-6,813 Reduced 11.98%
50,078 $14.1 Million
Q1 2022

May 16, 2022

SELL
$221.42 - $260.97 $2.63 Million - $3.1 Million
-11,892 Reduced 17.29%
56,891 $14.8 Million
Q4 2021

Feb 11, 2022

BUY
$177.01 - $223.45 $131,695 - $166,246
744 Added 1.09%
68,783 $15.1 Million
Q3 2021

Nov 15, 2021

BUY
$181.39 - $202.99 $275,894 - $308,747
1,521 Added 2.29%
68,039 $13.1 Million
Q2 2021

Aug 13, 2021

BUY
$187.49 - $221.1 $1.46 Million - $1.72 Million
7,789 Added 13.26%
66,518 $13.2 Million
Q1 2021

May 17, 2021

BUY
$207.02 - $241.31 $4.78 Million - $5.58 Million
23,104 Added 64.85%
58,729 $12.6 Million
Q4 2020

Feb 16, 2021

BUY
$207.01 - $276.09 $1.54 Million - $2.05 Million
7,426 Added 26.33%
35,625 $8.36 Million
Q3 2020

Nov 13, 2020

BUY
$255.65 - $303.1 $910,369 - $1.08 Million
3,561 Added 14.45%
28,199 $7.67 Million
Q2 2020

Aug 14, 2020

BUY
$225.48 - $295.8 $2.03 Million - $2.66 Million
8,998 Added 57.53%
24,638 $7.15 Million
Q1 2020

May 13, 2020

BUY
$199.77 - $247.81 $651,449 - $808,108
3,261 Added 26.34%
15,640 $3.72 Million
Q4 2019

Feb 12, 2020

BUY
$166.71 - $223.91 $292,909 - $393,409
1,757 Added 16.54%
12,379 $2.71 Million
Q3 2019

Nov 05, 2019

BUY
$166.23 - $187.09 $616,713 - $694,103
3,710 Added 53.67%
10,622 $1.8 Million
Q2 2019

Jul 10, 2019

BUY
$164.61 - $190.37 $768,564 - $888,837
4,669 Added 208.16%
6,912 $1.23 Million
Q1 2019

Apr 05, 2019

BUY
$163.73 - $194.7 $367,246 - $436,712
2,243 New
2,243 $413,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Pfs Investments Inc. Portfolio

Follow Pfs Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfs Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pfs Investments Inc. with notifications on news.